Occudo Quantitative Strategies’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
28,054
-29,860
-52% -$3.09M 0.15% 197
2026
Q1
$5.79M Buy
+57,914
New +$5.94M 0.32% 90
2025
Q4
Sell
-7,767
Closed -$987K 747
2025
Q3
$987K Buy
7,767
+5,068
+188% +$603K 0.12% 238
2025
Q2
$331K Sell
2,699
-7,509
-74% -$858K 0.04% 442
2025
Q1
$1.03M Buy
+10,208
New +$997K 0.14% 217
2021
Q4
Sell
-11,444
Closed -$683K 1112
2021
Q3
$683K Buy
+11,444
New +$720K 0.08% 418
2021
Q2
Sell
-5,372
Closed -$350K 925
2021
Q1
$350K Buy
+5,372
New +$350K 0.08% 444

Other funds holding EHC

Occudo Quantitative Strategies's EHC Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Encompass Health (EHC) stake by 52% in Q2 2026, selling an estimated $3.09M and leaving 28,054 shares worth $2.84M. The position accounts for 0.15% of the portfolio, ranked #197.

Occudo Quantitative Strategies first reported a position in EHC in Q1 2021 and has held it in 7 quarters since. The position peaked at $5.79M in Q1 2026. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Occudo Quantitative Strategies held 28,054 shares of Encompass Health worth $2.84M as of Q2 2026.
  • Occudo Quantitative Strategies sold 29,860 Encompass Health shares in Q2 2026, an estimated $3.09M.
  • Encompass Health made up 0.15% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #197 holding.
  • Occudo Quantitative Strategies first reported a position in Encompass Health in Q1 2021 and has held it in 7 quarters since.
  • Occudo Quantitative Strategies's Encompass Health position peaked at $5.79M in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.